Energy » Fossil Fuels | Changsheng Biotechnology Co. Ltd.

Changsheng Biotechnology Co. Ltd. A | Cash Flow

Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
35,736.20
207,855.90
293,082.10
428,586.30
567,671.10
Depreciation, Depletion & Amortization
9,096.10
24,104.40
26,989.40
32,076.00
35,643.40
Other Funds
-
28,936.00
1,616,764.00
41.10
33,819.50
Funds from Operations
47,157.20
261,911.60
344,047.20
467,470.40
602,190.20
Changes in Working Capital
27,841.10
63,624.40
154,368.70
116,778.20
34,299.20
Net Operating Cash Flow
19,316.10
198,287.20
189,678.50
350,692.20
567,891.10
Capital Expenditures
36,867.80
62,054.50
68,332.20
56,221.20
319,009.50
Sale of Fixed Assets & Businesses
44.40
88.20
436.40
1,356.10
592.20
Purchase/Sale of Investments
-
58,000.00
15,850.00
1,775,000.00
149,226.60
Net Investing Cash Flow
36,823.40
111,136.30
101,528.70
1,839,906.60
466,903.90
Cash Dividends Paid - Total
14,400.00
102,774.90
-
145,408.60
290,817.10
Issuance/Reduction of Debt, Net
-
5,500.00
100,000.00
56,500.00
5,500.00
Net Financing Cash Flow
14,400.00
68,338.90
1,516,764.00
201,949.70
262,497.60
Net Change in Cash
32,345.60
18,644.60
1,809,167.80
1,689,276.40
164,020.00
Free Cash Flow
17,551.70
136,232.70
121,346.30
294,471.00
248,881.60
Deferred Taxes & Investment Tax Credit
283.90
10,696.40
4,855.50
6,940.90
25,822.10
Net Assets from Acquisitions
-
-
-
11,795.40
-
Other Sources
-
8,830.00
358,574.50
1,753.90
740.00
Exchange Rate Effect
438.30
167.40
1,196.70
1,887.70
2,509.70
Other Uses
-
-
205,000.00
-
-

About Changsheng Biotechnology Co.

View Profile
Address
No. 1615 Yueda Road
Changchun Jilin 130103
China
Employees -
Website -
Updated 07/08/2019
Changsheng Bio-technology Co., Ltd. engages in the manufacture, research and development, and sale of human vaccines. Its products include vaccine for DTC combines, rabies F and V, varicella, influenza, and hepatitis A. The company was founded on August 18, 1992 and is headquartered in Changchun, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.